2023
Race, geography, and risk of breast cancer treatment delays: A population‐based study 2004–2015
Reeder‐Hayes K, Jackson B, Baggett C, Kuo T, Gaddy J, LeBlanc M, Bell E, Green L, Wheeler S. Race, geography, and risk of breast cancer treatment delays: A population‐based study 2004–2015. Cancer 2023, 129: 925-933. PMID: 36683417, DOI: 10.1002/cncr.34573.Peer-Reviewed Original ResearchConceptsBreast cancer treatment delaysTreatment delayMagnitude of racial disparitiesNon-Black patientsStage I-III breast cancerI-III breast cancerPoor-quality carePopulation health resourcesRisk of treatment delayBlack patientsBreast cancer survivalCancer treatment delayPopulation-based studyDiagnosis to first treatmentAssociated with riskBreast cancerCancer RegistryObservational cohort of patientsTreatment delay >Health resourcesPopulation-basedPoisson regressionCancer survivalSociodemographic dataRacial disparitiesObesity, Cancer, and Health Equity
Nyrop K, Gaddy J, Charlot M. Obesity, Cancer, and Health Equity. American Journal Of Preventive Medicine 2023, 64: 595-598. PMID: 36610923, DOI: 10.1016/j.amepre.2022.10.024.Peer-Reviewed Original ResearchSeeking Racial Equity in Hematology and Oncology: a Fellow-Led Educational Series to Promote Reflection and Action
Stein J, Gaddy J, Sorah J, Wooten M, Gibson K, Collichio F. Seeking Racial Equity in Hematology and Oncology: a Fellow-Led Educational Series to Promote Reflection and Action. Journal Of Cancer Education 2023, 38: 1241-1244. PMID: 36598746, PMCID: PMC10463164, DOI: 10.1007/s13187-022-02255-8.Peer-Reviewed Original ResearchConceptsGraduate medical education programsHealth system levelMedical education programsEffects of implicit biasImproved comfort levelRacial inequalitySystemic racismAwareness of racial inequalityMedical residentsImprove awarenessRacial equityImprove knowledgeGroup discussionsEducation programsUniversity of North CarolinaLikert scaleEducation seriesImplicit biasComfort levelLay mediaEducational gapLived experiencePerceptions of racial inequalityParticipantsEducation curriculum
2022
Addressing Racial, Ethnic, and Age Disparities in Cancer Clinical Trial Enrollment
Gaddy JJ, Gross CP. Addressing Racial, Ethnic, and Age Disparities in Cancer Clinical Trial Enrollment. JAMA Oncology 2022, 8: 1792-1793. PMID: 36301581, DOI: 10.1001/jamaoncol.2022.5006.Peer-Reviewed Original Research
2021
The Ethical Imperative of Equity in Oncology: Lessons Learned From 2020 and a Path Forward.
Marron J, Charlot M, Gaddy J, Rosenberg A. The Ethical Imperative of Equity in Oncology: Lessons Learned From 2020 and a Path Forward. American Society Of Clinical Oncology Educational Book 2021, 41: e13-e19. PMID: 34061560, DOI: 10.1200/edbk_100029.Peer-Reviewed Original ResearchConceptsU.S. health careOncology communityProfessional medical organizationsCancer careRacial/ethnic disparitiesOncology workforceHealth careStructural racismMedical organizationsOncologyClinical practiceEthical principlesEthical responsibilityPracticing oncologistsEthical imperativesCareCOVID-19 pandemicOptimize equityUnited StatesCOVID-19CommunityDisparitiesWork—andInequalityWorkforce
2016
Racial/Ethnic Disparity in Treatment for Prostate Cancer: Does Cancer Severity Matter?
Moses K, Orom H, Brasel A, Gaddy J, Underwood W. Racial/Ethnic Disparity in Treatment for Prostate Cancer: Does Cancer Severity Matter? Urology 2016, 99: 76-83. PMID: 27667157, PMCID: PMC5191943, DOI: 10.1016/j.urology.2016.07.045.Peer-Reviewed Original ResearchConceptsProstate cancerOdds of receiving treatmentReceipt of treatmentDefinitive treatmentHispanic menWhite menD'Amico risk classificationDisease severityContext of disease severityOdds of treatmentLogistic regression analysisApproach to treatmentIntermediate-riskDecreased oddsHigh riskAA menAsian menRisk categoriesRisk classificationCancerProstateTreatmentRegression analysisMenTreatment variationRacial/ethnic differences in the relative risk of receipt of specific treatment among men with prostate cancer
Moses K, Orom H, Brasel A, Gaddy J, Underwood W. Racial/ethnic differences in the relative risk of receipt of specific treatment among men with prostate cancer. Urologic Oncology Seminars And Original Investigations 2016, 34: 415.e7-415.e12. PMID: 27161898, PMCID: PMC4996674, DOI: 10.1016/j.urolonc.2016.04.002.Peer-Reviewed Original ResearchConceptsReceipt of radical prostatectomyRadiation therapyProstate cancerRelative risk ratiosCombination therapyDefinitive treatmentExternal beam radiation therapyBeam radiation therapyWhite menEnd Results ProgramHispanic menLogistic regression analysisPredictors of receiptRadical prostatectomyImprove physician educationSignificant public health issueEnd ResultsBrachytherapySpecific treatmentRisk ratioProstateAA menAfrican AmericansRelative riskCryotherapy